Telix Pharmaceuticals Aktie

15,50 EUR -1,60 EUR -9,36 %

14.03.2025

FSE

17,21 USD +0,24 USD +1,41 %

14.03.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Bei einem anderen Broker handeln Smartphone

Marktkap.5,36 Mrd. EUR

KGV154,93Div. Rendite0,00%

WKNA40FCQ

ISINUS87961M1053

SymbolTLX

Telix Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

13.03.25PR NewswireTelix Adds Lead-212 Isotope Production Capability

12.03.25PR NewswireTelix Adds Lead-212 Isotope Production Capability

03.03.25PR NewswireInvestor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

26.02.25PR NewswireFDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

25.02.25PR NewswireIlluccix® Prostate Cancer Imaging Agent Approved in Luxembourg

24.02.25PR NewswireTelix's Illuccix® PSMA-PET Imaging Agent Approved in Norway

20.02.25PR NewswireTelix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

12.02.25PR NewswireIlluccix® Approved in the United Kingdom

11.02.25PR NewswireIlluccix® Approved in Denmark

30.01.25PR NewswireTelix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

27.01.25PR NewswireTelix Completes Acquisition of RLS (USA) Inc.

22.01.25PR NewswireImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

16.01.25PR NewswireIlluccix® Receives European Approval

13.01.25PR NewswireTelix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

13.01.25PR NewswireTelix Exceeds FY24 Guidance with US$142M Q4 Revenue

13.01.25PR NewswireScintimun® Commercialization Partnership with Curium Pharma

12.01.25PR NewswireTelix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

30.12.24PR NewswireNOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

29.12.24PR NewswireTelix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

19.12.24PR NewswireTelix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

28.11.24PR NewswireFirst Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

19.11.24PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline

18.11.24PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline

13.11.24PR NewswireTelix and Eckert & Ziegler to Partner on Actinium-225 Production Technology

03.11.24PR NewswireTelix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals

30.10.24PR NewswireTelix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®

24.10.24PR NewswireFDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

22.10.24PR NewswireTelix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals

17.10.24PR NewswireTelix Files Form 20-F Registration Statement for Nasdaq ADS

Telix Pharmaceuticals News

Telix Pharmaceuticals News: auf dieser Seite finden Sie alle Telix Pharmaceuticals News und Nachrichten zur Telix Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Telix Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Telix Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.